Possible role of phosphoinositide-3-kinase in Mx1 protein translation and antiviral activity of interferon-omega-stimulated HeLa cells

Pharmacology

Volumn 87, Issue 3-4, 2011, Pages 224-231

  Seo, Youngjun ^a   Kim, Mihee ^a   Choi, Minjoung ^a   Kim, Sunhee ^a   Park, Kidae ^a   Oh, Ilung ^a   Chung, Seungtae ^a   Suh, Hongwon ^a   Hong, Seunghwa ^a   Park, Suenie ^a  

^a Korea Food and Drug Administration   (South Korea)

Author keywords

Antiviral response; HeLa cells, interferon stimulated; Phosphoinositide 3 kinase

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MYXOVIRUS RESISTANCE PROTEIN; MYXOVIRUS RESISTANCE PROTEIN 1; OMEGA INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P70; S6 KINASE; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE CONTROL; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION INITIATION;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; ENCEPHALOMYOCARDITIS VIRUS; GTP-BINDING PROTEINS; HELA CELLS; HUMANS; INTERFERON TYPE I; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BIOSYNTHESIS; VERO CELLS; VESICULOVIRUS;

EID: 79952823854     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324536     Document Type: Article

References (34)

1. Isaacs A, Lindenmann J: Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147: 258-267.
2. Pestka S, Krause CD, Walter MR: Interferons, interferon-like cytokines, and their receptors. Immunol Rev 2004; 202: 8-32. (Pubitemid 39576902)
3. Pestka S, Langer JA, Zoon KC, Samuel CE: Interferons and their actions. Annu Rev Biochem 1987; 56: 727-777. (Pubitemid 17105465)
4. Pestka S: The interferons: 50 years after their discovery, there is much more to learn. J Biol Chem 2007; 282: 20047-20051. (Pubitemid 47099975)
5. Adolf GR: Human interferon omega - a review. Mult Scler 1995; 1(suppl 1):S44-S47.
6. Domanski P, Colamonici OR: The type I interferon receptor. The long and short of it. Cytokine Growth Factor Rev 1996; 7: 143-151. (Pubitemid 27198073)
7. Brierley MM, Fish EN: Review: IFN-alpha/ beta receptor interactions to biologic outcomes: understanding the circuitry. J Interferon Cytokine Res 2002; 22: 835-845. (Pubitemid 35217514)
8. Buckwold VE, Wei J, Huang Z, Huang C, Nalca A, Wells J, Russell J, Collins B, Ptak R, Lang W, Scribner C, Blanchett D, Alessi T, Langecker P: Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses. Antiviral Res 2007; 73: 118-125. (Pubitemid 46138065)
9. Platanias LC: Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5: 375-386. (Pubitemid 40685987)
10. Mayer IA, Verma A, Grumbach IM, Uddin S, Lekmine F, Ravandi F, Majchrzak B, Fujita S, Fish EN, Platanias LC: The p38 mapk pathway mediates the growth inhibitory effects of interferon-alpha in bcr-abl-expressing cells. J Biol Chem 2001; 276: 28570-28577.
11. Li Z, Tran TT, Ma JY, O'Young G, Kapoun AM, Chakravarty S, Dugar S, Schreiner G, Protter AA: p38 alpha mitogen-activated protein kinase inhibition improves cardiac function and reduces myocardial damage in isoproterenol-induced acute myocardial injury in rats. J Cardiovasc Pharmacol 2004; 44: 486-492. (Pubitemid 39305091)
12. Lei H, Furlong PJ, Ra JH, Mullins D, Cantor R, Fraker DL, Spitz FR: Akt activation and response to interferon-beta in human cancer cells. Cancer Biol Ther 2005; 4: 709-715. (Pubitemid 41351168)
13. Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM: Interferon alpha/beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. J Biol Chem 2001; 276: 13756-13761.
14. Kaur S, Uddin S, Platanias LC: The PI3′kinase pathway in interferon signaling. J Interferon Cytokine Res 2005; 25: 780-787.
15. Prejean C, Sarma T, Kurnasov O, Usacheva A, Hemmings B, Cantley L, Fruman DA, Morrison LA, Buller RM, Colamonici OR: Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream effectors. J Immunol 2001; 167: 4553-4559. (Pubitemid 32954334)
16. Kaur S, Sassano A, Dolniak B, Joshi S, Majchrzak-Kita B, Baker DP, Hay N, Fish EN, Platanias LC: Role of the Akt pathway in mRNA translation of interferon-stimulated genes. Proc Natl Acad Sci USA 2008; 105: 4808-4813. (Pubitemid 351753828)
17. Council of Europe (COE): Statistical analysis of results of biological assays and tests. Strasbourg, European Directorate for the Quality of Medicines (EDQM), 2007.
18. Son YW, Shin W, Jung JY, Oh IW, Jin JH, Park SY, Park TS: Study on recombinant interferon- alpha standardization. Annu Rep KFDA 2000; 4: 598-606.
19. Theofilopoulos AN, Baccala R, Beutler B, Kono DH: Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005; 23: 307-336. (Pubitemid 40563172)
20. Domanski P, Nadeau OW, Platanias LC, Fish E, Kellum M, Pitha P, Colamonici OR: Differential use of the betal subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta. J Biol Chem 1998; 273: 3144-3147. (Pubitemid 28109720)
21. Platanias LC: The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol Ther 2003; 98: 129-142. (Pubitemid 36519168)
22. Li Y, Sassano A, Majchrzak B, Deb DK, Levy DE, Gaestel M, Nebreda AR, Fish EN, Platanias LC: Role of p38alpha MAP kinase in type I interferon signaling. J Biol Chem 2004; 279: 970-979. (Pubitemid 38082618)
23. Knauf U, Tschopp C, Gram H: Negative regulation of protein translation by mitogenactivated protein kinase-interacting kinases 1 and 2. Mol Cell Biol 2001; 21: 5500-5511. (Pubitemid 32702454)
24. Soloaga A, Thomson S, Wiggin GR, Rampersaud N, Dyson MH, Hazzalin CA, Mahadevan LC, Arthur JS: MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG- 14. EMBO J 2003; 22: 2788-2797. (Pubitemid 36712374)
25. Waskiewicz AJ, Flynn A, Proud CG, Cooper JA: Mitogen-activated protein kinases activate the serine/threonine kinases MNK1 and MNK2. EMBO J 1997; 16: 1909-1920. (Pubitemid 27170952)
26. Deane JA, Fruman DA: Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu Rev Immunol 2004; 22: 563-598. (Pubitemid 38680434)
27. Cantley LC: The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657. (Pubitemid 34579158)
28. Sadler AJ, Williams BR: Interferon-inducible antiviral effectors. Nat Rev Immunol 2008; 8: 559-568. (Pubitemid 351913674)
29. Haller O, Kochs G: Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 2002; 3: 710-717.
30. Lekmine F, Sassano A, Uddin S, Smith J, Majchrzak B, Brachmann SM, Hay N, Fish EN, Platanias LC: Interferon-gamma engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp Cell Res 2004; 295: 173-182. (Pubitemid 38407355)
31. Lekmine F, Uddin S, Sassano A, Parmar S, Brachmann SM, Majchrzak B, Sonenberg N, Hay N, Fish EN, Platanias LC: Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J Biol Chem 2003; 278: 27772-27780. (Pubitemid 36899968)
32. Bjornsti MA, Houghton PJ: The TOR pathway: a target for cancer therapy. Nat Rev Cancer 2004; 4: 335-348.
33. Gingras AC, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R, Sonenberg N: Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev 2001; 15: 2852-2864. (Pubitemid 33042055)
34. Nguyen H, Ramana CV, Bayes J, Stark GR: Roles of phosphatidylinositol 3-kinase in interferon- gamma-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J Biol Chem 2001; 276: 33361-33368.